share_log

HC Wainwright & Co. Maintains Buy on Panbela Therapeutics, Lowers Price Target to $5

HC Wainwright & Co. Maintains Buy on Panbela Therapeutics, Lowers Price Target to $5

HC Wainwright & Co.维持对Panbela Therapeutics的买入,将目标股价下调至5美元
Moomoo 24/7 ·  04/02 08:49

HC Wainwright & Co. analyst Joseph Pantginis maintains Panbela Therapeutics (OTC:PBLA) with a Buy and lowers the price target from $16 to $5.

HC Wainwright & Co. 分析师约瑟夫·潘吉尼斯维持Panbela Therapeutics(场外交易代码:PBLA)的买入并将目标股价从16美元下调至5美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发